Brown adipocytes are potential therapeutic targets for obesity-related metabolic diseases and stimulate FGF21 expression by regulating the molecular clock brain and muscle Arnt-like 1 in brown adipocytes. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.